<DOC>
	<DOCNO>NCT01384279</DOCNO>
	<brief_summary>The primary aim study investigate efficacy metformin topiramate second-generation antipsychotic-induced obesity . The secondary domain look adverse effect drug . The investigator hypothesize metformin topiramate effective treating obesity induce second-generation antipsychotic .</brief_summary>
	<brief_title>The Therapeutic Effects Topiramate Metformin Second Generation Antipsychotics-induced Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Diagnosis : schizophrenia schizoaffective disorder 2 . Age : 20 65 3 . BMI &gt; 27 4 . Receiving secondgeneration antipsychotic ( Olanzapine , Clozapine , Quetiapine , Risperidone , Amisulpride , Zotepine ) 1 . Allergy metformin topiramate 2 . Currently take metformin topiramate 3 . Currently take drug may interact topiramate , include carbamazepine , eslicarbazepine , oxcarbazepine , phenobarbital , phenytoin , primidone , amitriptyline , lithium , metformin , propranolol , sumatriptan . 4 . Being pregnant plan become pregnant study period , 5 . History hypertension , DM , liver renal function impairment , cardiovascular disease , CVA , neurological disorder 6 . History hypoglycemia 7 . History suicidal attempt 8 . Current scale Hamilton Depression Rating Scale &gt; 8</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>metformin</keyword>
	<keyword>topiramate</keyword>
	<keyword>obesity</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>